Novartis Ag (NVS) Consolidated Net Income (2009 - 2026)
Novartis Ag's Consolidated Net Income came in at $3.26 billion for Q2 2026, down 19.1% from $4.02 billion a year earlier and down 28.0% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Consolidated Net Income (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Novartis Ag reported Consolidated Net Income of $34.13 billion, down 17.9% year-over-year; for FY2025, it came in at $13.97 billion, up 17.0% from FY2024.
- Consolidated Net Income carries a five-year compound annual growth rate of 11.6% (FY2020 to FY2025).
- Going back by year, Consolidated Net Income was $11.94 billion in FY2024 (-19.6%), $14.85 billion in FY2023 (+113.6%), $6.96 billion in FY2022 (-71.0%) and $24.02 billion in FY2021 (+197.6%).
- The Q2 2026 figure represents the lowest quarterly Consolidated Net Income since Q2 2024.
- Year-over-year, Consolidated Net Income increased in four of the last eight quarters, with an average decline of 12.2%.
- The fastest year-over-year change in Consolidated Net Income over five years came in Q4 2021 (growth of 587.6%), and the weakest in Q3 2025 (a decline of 65.2%).
- Business Quant data shows NVS's Consolidated Net Income at $4.52 billion (Q1 2026), $21.89 billion (Q4 2025) and $4.46 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Vertex Pharmaceuticals | 129.23 Bn | 101.23 Bn | 2.84 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.26 Bn |
| Mar 31, 2026 | 3.16 Bn |
| Dec 31, 2025 | 2.40 Bn |
| Sep 30, 2025 | 3.93 Bn |
| Jun 30, 2025 | 4.02 Bn |
| Mar 31, 2025 | 3.61 Bn |
| Dec 31, 2024 | 2.82 Bn |
| Sep 30, 2024 | 3.19 Bn |
| Jun 30, 2024 | 3.25 Bn |
| Mar 31, 2024 | 2.69 Bn |
| Dec 31, 2023 | 8.48 Bn |
| Sep 30, 2023 | 1.76 Bn |
| Jun 30, 2023 | 2.32 Bn |
| Mar 31, 2023 | 2.29 Bn |
| Dec 31, 2022 | 1.47 Bn |
| Sep 30, 2022 | 1.58 Bn |
| Jun 30, 2022 | 1.70 Bn |
| Mar 31, 2022 | 2.22 Bn |
| Dec 31, 2021 | 16.31 Bn |
| Sep 30, 2021 | 2.76 Bn |
API Access
Novartis Ag Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();